Axim Biotechnologies Stock Market Value
| AXIM Stock | USD 0.02 0 6.47% |
| Symbol | Axim |
Axim Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Axim Biotechnologies' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Axim Biotechnologies.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Axim Biotechnologies on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Axim Biotechnologies or generate 0.0% return on investment in Axim Biotechnologies over 90 days. Axim Biotechnologies is related to or competes with Zelira Therapeutics, and Sigyn Therapeutics. AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, an... More
Axim Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Axim Biotechnologies' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Axim Biotechnologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 14.19 | |||
| Information Ratio | 0.1321 | |||
| Maximum Drawdown | 76.67 | |||
| Value At Risk | (15.79) | |||
| Potential Upside | 21.43 |
Axim Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axim Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Axim Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Axim Biotechnologies historical prices to predict the future Axim Biotechnologies' volatility.| Risk Adjusted Performance | 0.1107 | |||
| Jensen Alpha | 1.92 | |||
| Total Risk Alpha | 0.5539 | |||
| Sortino Ratio | 0.127 | |||
| Treynor Ratio | (2.63) |
Axim Biotechnologies January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1107 | |||
| Market Risk Adjusted Performance | (2.62) | |||
| Mean Deviation | 9.11 | |||
| Semi Deviation | 8.92 | |||
| Downside Deviation | 14.19 | |||
| Coefficient Of Variation | 724.68 | |||
| Standard Deviation | 13.65 | |||
| Variance | 186.36 | |||
| Information Ratio | 0.1321 | |||
| Jensen Alpha | 1.92 | |||
| Total Risk Alpha | 0.5539 | |||
| Sortino Ratio | 0.127 | |||
| Treynor Ratio | (2.63) | |||
| Maximum Drawdown | 76.67 | |||
| Value At Risk | (15.79) | |||
| Potential Upside | 21.43 | |||
| Downside Variance | 201.43 | |||
| Semi Variance | 79.6 | |||
| Expected Short fall | (14.95) | |||
| Skewness | 1.36 | |||
| Kurtosis | 4.83 |
Axim Biotechnologies Backtested Returns
Axim Biotechnologies is out of control given 3 months investment horizon. Axim Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.07% are justified by taking the suggested risk. Use Axim Biotechnologies Mean Deviation of 9.11, risk adjusted performance of 0.1107, and Downside Deviation of 14.19 to evaluate company specific risk that cannot be diversified away. Axim Biotechnologies holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.71, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Axim Biotechnologies are expected to decrease at a much lower rate. During the bear market, Axim Biotechnologies is likely to outperform the market. Use Axim Biotechnologies total risk alpha and the relationship between the potential upside and day typical price , to analyze future returns on Axim Biotechnologies.
Auto-correlation | -0.44 |
Modest reverse predictability
Axim Biotechnologies has modest reverse predictability. Overlapping area represents the amount of predictability between Axim Biotechnologies time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Axim Biotechnologies price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Axim Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.